All In Biotech

Drug Trial Radar · NCT04786769

Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency

A Randomized Clinical Trial of Intravenous Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency

Last checked: Nov 20, 2026Latest source record: Mar 8, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 2,500 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

2,500

Planned (sponsor's estimate)

Start

Jan 2022

Primary completion

Jan 2025

Study completion Jun 2025

Sponsor

Lead sponsor
Hospital de Santa Cruz, PortugalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 8, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The INERTIA trial is a multicenter double-blinded randomized trial of intravenous iron supplementation in patients with severe aortic stenosis and iron deficiency undergoing TAVI or SAVR. The primary endpoint is the time to HF hospital admission or cardiovascular death. Secondary endpoints will assess quality of life indicators and functional capacity at 6 months.

Conditions

  • Aortic Stenosis
  • Iron-deficiency

Interventions

  • Ferric carboxymaltoseDrug

    Intravenous ferric carboxymaltose according to baseline weight and hemoglobin

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of patients with heart failure hospital admission or cardiovascular deathTime frame: up to 52 weeks

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.